铂-话题@MedSci

#铂#

382篇内容 | 6038人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737532, encodeId=ce061e37532cd, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失, objectType=article, longId=108637, objectId=097710863e73, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=097710863e73, replyNumber=0, likeNumber=69, createdTime=2018-05-25, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=097710863e73, moduleTitle=Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=097710863e73)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737494, encodeId=31181e3749487, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, objectType=article, longId=79605, objectId=925ae9605d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925ae9605d0, replyNumber=0, likeNumber=63, createdTime=2017-04-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925ae9605d0, moduleTitle=NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925ae9605d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737530, encodeId=13af1e3753057, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗, objectType=article, longId=108311, objectId=a8c210831193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8c210831193, replyNumber=0, likeNumber=62, createdTime=2018-02-07, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8c210831193, moduleTitle=Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8c210831193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737504, encodeId=08831e375045c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, objectType=article, longId=96885, objectId=7d279688506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d279688506, replyNumber=0, likeNumber=55, createdTime=2017-12-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d279688506, moduleTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d279688506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737496, encodeId=e37b1e374968c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：男性临床I期精原细胞癌卡铂辅助化疗后复发状况调查, objectType=article, longId=83364, objectId=5933833646a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5933833646a, replyNumber=0, likeNumber=61, createdTime=2017-06-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5933833646a, moduleTitle=JCO：男性临床I期精原细胞癌卡铂辅助化疗后复发状况调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5933833646a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737492, encodeId=2aa11e37492f7, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！, objectType=article, longId=78561, objectId=ee77e856177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee77e856177, replyNumber=0, likeNumber=43, createdTime=2017-08-17, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee77e856177, moduleTitle=新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee77e856177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737522, encodeId=d11a1e375225a, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=CLIN CANCER RES：三阴性乳腺癌铂基新辅助化疗期间肿瘤BRCA1反向突变增加且与治疗抵抗有关, objectType=article, longId=105038, objectId=7f6e10503832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f6e10503832, replyNumber=0, likeNumber=86, createdTime=2018-02-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f6e10503832, moduleTitle=CLIN CANCER RES：三阴性乳腺癌铂基新辅助化疗期间肿瘤BRCA1反向突变增加且与治疗抵抗有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f6e10503832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737512, encodeId=08681e3751287, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=奥沙利铂治疗肝细胞癌耐药的相关机制研究进展, objectType=article, longId=100352, objectId=d9291003529e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9291003529e, replyNumber=0, likeNumber=73, createdTime=2017-11-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9291003529e, moduleTitle=奥沙利铂治疗肝细胞癌耐药的相关机制研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9291003529e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737505, encodeId=7a311e3750570, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Sci Rep：丙酮酸激酶M2的抑制明显的减弱了晚期膀胱癌对铂化合物的化学抵抗性, objectType=article, longId=97625, objectId=2bc69e625ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bc69e625ee, replyNumber=0, likeNumber=61, createdTime=2017-12-03, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bc69e625ee, moduleTitle=Sci Rep：丙酮酸激酶M2的抑制明显的减弱了晚期膀胱癌对铂化合物的化学抵抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bc69e625ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737501, encodeId=7f631e37501f0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=NAT MED：含铂化疗剂以介导核糖体合成应激反应的方式杀伤细胞, objectType=article, longId=91177, objectId=1f8b911e725, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8b911e725, replyNumber=0, likeNumber=82, createdTime=2017-04-23, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8b911e725, moduleTitle=NAT MED：含铂化疗剂以介导核糖体合成应激反应的方式杀伤细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8b911e725)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737503, encodeId=acfe1e3750351, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：精原细胞瘤复发----卡铂辅助治疗疗效如何？, objectType=article, longId=95495, objectId=931395495a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=931395495a9, replyNumber=0, likeNumber=54, createdTime=2018-02-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=931395495a9, moduleTitle=J Clin Oncol：精原细胞瘤复发----卡铂辅助治疗疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=931395495a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737502, encodeId=c8dd1e375021e, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=波士顿科学铂铬合金依维莫司洗脱冠状动脉支架系统SYNERGY上市, objectType=article, longId=94263, objectId=82639426362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82639426362, replyNumber=0, likeNumber=69, createdTime=2017-10-03, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82639426362, moduleTitle=波士顿科学铂铬合金依维莫司洗脱冠状动脉支架系统SYNERGY上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82639426362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737491, encodeId=e5fd1e3749144, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JAMA Oncol：根据结肠癌亚型决定是否使用奥沙利铂, objectType=article, longId=77113, objectId=47cce711357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47cce711357, replyNumber=0, likeNumber=55, createdTime=2016-09-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47cce711357, moduleTitle=JAMA Oncol：根据结肠癌亚型决定是否使用奥沙利铂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47cce711357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737499, encodeId=90ab1e374999b, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：精准化疗前路崎岖：ERCC1预测NSCLC铂类化疗结果不理想, objectType=article, longId=87800, objectId=c9238e80082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9238e80082, replyNumber=0, likeNumber=69, createdTime=2017-03-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9238e80082, moduleTitle=JCO：精准化疗前路崎岖：ERCC1预测NSCLC铂类化疗结果不理想, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9238e80082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737500, encodeId=b2f81e3750027, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet：ALK重排的非鳞状NSCLC患者ceritinib和铂类为基础的化疗哪个更好？, objectType=article, longId=88050, objectId=e01e880500f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01e880500f, replyNumber=0, likeNumber=66, createdTime=2017-08-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01e880500f, moduleTitle=Lancet：ALK重排的非鳞状NSCLC患者ceritinib和铂类为基础的化疗哪个更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01e880500f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737497, encodeId=36a31e3749776, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet子刊：硫代硫酸钠可防止儿童使用顺铂造成的听觉损伤, objectType=article, longId=83765, objectId=7d0583e6572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0583e6572, replyNumber=0, likeNumber=54, createdTime=2017-01-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0583e6572, moduleTitle=Lancet子刊：硫代硫酸钠可防止儿童使用顺铂造成的听觉损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0583e6572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737490, encodeId=a2621e374902b, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet：中山大学张力教授证实吉西他滨联合顺铂可延长晚期鼻咽癌患者的无进展生存期, objectType=article, longId=75834, objectId=2e28e58346e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e28e58346e, replyNumber=0, likeNumber=59, createdTime=2017-01-30, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e28e58346e, moduleTitle=Lancet：中山大学张力教授证实吉西他滨联合顺铂可延长晚期鼻咽癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e28e58346e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737493, encodeId=31041e3749346, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布, objectType=article, longId=79100, objectId=72a1e9100af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72a1e9100af, replyNumber=0, likeNumber=29, createdTime=2017-04-19, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72a1e9100af, moduleTitle=2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72a1e9100af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737485, encodeId=f3e61e37485b6, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效, objectType=article, longId=63038, objectId=409463038a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409463038a2, replyNumber=0, likeNumber=87, createdTime=2016-11-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409463038a2, moduleTitle=JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=409463038a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737489, encodeId=e1541e37489a0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), objectType=article, longId=73685, objectId=920ee368569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920ee368569, replyNumber=0, likeNumber=67, createdTime=2017-06-25, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920ee368569, moduleTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920ee368569)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Otol Neurotol：口服候选临床阶段药物SENS-401可以有效的减少铂引起的听力损失

2018-05-25

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

NEJM：Niraparib可显著延长铂敏感的复发性卵巢癌患者无进展生存期

2017-04-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol:表阿霉素/顺铂/卡培他滨新辅助治疗食管腺癌并不优于标准治疗

2018-02-07

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率

2017-12-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：男性临床I期精原细胞癌卡铂辅助化疗后复发状况调查

2017-06-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

新的基因学研究帮助化疗患者摆脱顺铂耐药性的困扰！

2017-08-17

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

CLIN CANCER RES：三阴性乳腺癌铂基新辅助化疗期间肿瘤BRCA1反向突变增加且与治疗抵抗有关

2018-02-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

奥沙利铂治疗肝细胞癌耐药的相关机制研究进展

2017-11-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Sci Rep：丙酮酸激酶M2的抑制明显的减弱了晚期膀胱癌对铂化合物的化学抵抗性

2017-12-03

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

NAT MED：含铂化疗剂以介导核糖体合成应激反应的方式杀伤细胞

2017-04-23

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：精原细胞瘤复发----卡铂辅助治疗疗效如何？

2018-02-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

波士顿科学铂铬合金依维莫司洗脱冠状动脉支架系统SYNERGY上市

2017-10-03

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JAMA Oncol：根据结肠癌亚型决定是否使用奥沙利铂

2016-09-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：精准化疗前路崎岖：ERCC1预测NSCLC铂类化疗结果不理想

2017-03-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet：ALK重排的非鳞状NSCLC患者ceritinib和铂类为基础的化疗哪个更好？

2017-08-04

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet子刊：硫代硫酸钠可防止儿童使用顺铂造成的听觉损伤

2017-01-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet：中山大学张力教授证实吉西他滨联合顺铂可延长晚期鼻咽癌患者的无进展生存期

2017-01-30

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

2016注射用洛铂在原发性肝癌TACE治疗中的专家共识发布

2017-04-19

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JNCI：缺陷错配修复结肠癌III患者采用氟尿嘧啶联合奥沙利铂辅助化疗有效

2016-11-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期)

2017-06-25

科室
- - 订阅+
  - 更多科室
工具
服务